Urgent: Hydroxycut Lawsuits Have Already Been Filed
On May 1, 2009, there was a recall of 14 Hydroxycut diet-aid products stemming from a number of reports that folks using the products were developing heavy liver problems and other health concerns. Less than 7 days later, on May four, the first Hydroxycut class action lawsuit was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Class Action Lawsuit alleges company failure in informing the public about potential hazards of the products. Naturally, it’s too shortly to understand the suit is going to turn out, but if the company had information which it did not reveal to consumers, it should definitely be held accountable.
A class action legal action is filed by a bunch of people, all of whom have similar claims against a certain company. Filing a class action is just as effective, and a lot less dear, than filing an individual suit. As a rule, filing a class action court action will not cost you anything unless there’s a settlement. At that time, the lawyer who handled the suit will take his charges from the compensation that was given and then share the remaining funds to the litigants in the case. Since this is the case, you’ll be able to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the explanations that class action suits became so popular.
The 1st class action legal action against Iovate was filed in Canada where the company is found and represents all Canadian voters who sustained health issues due to Hydroxycut products. The FDA recall occurred in the US where 23 cases of liver disorders and other health issues had been reported. Health Canada failed to receive any reports of liver damage due to the diet products, but they did receive 17 reports concerning people who sustained breathing, neurological, cardiovascular, and gut problems as a consequence of Canadians using the products.
The Hydroxycut Liver Damage Suits alleges that the company sold the general public of the health risks that they could exposing buyers to. The complaint states that the company failed to publish the data on the product labels stating that users could run the risk of liver and kidney damage as well as gastrointestinal, cardiovascular, respiratory, and neurological issues. The suit goes on to claim this was an obvious omission on the part of the company which deliberately misled consumers concerning the security of the products.
